Skip to main content

DAFNA Capital Management LLC

13F filer · CIK 0001389933
Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$524MU.S. long equity reported on 13F
Positions8614 new · 8 closed
Net flow last quarter-$8.92MBuys minus sells
Top 10 positions weight52.9%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 202686 positions
RVMDRevolution Medicines, Inc.$105M20.09%0.26%-3.1%Q4 2020
CMPSCOMPASS Pathways plc$28.5M5.43%1.48%-16.8%Q1 2022
STXSStereotaxis, Inc.$23.5M4.49%14.00%Not reportedQ2 2013
NKTRNektar Therapeutics$22.2M4.24%1.56%+92.8%Q2 2025
DNLIDenali Therapeutics Inc.$19M3.62%0.46%+132.0%Q1 2025
IDYAIDEAYA Biosciences, Inc.$18.5M3.53%0.52%+4.3%Q3 2020
ATRCAtriCure, Inc.$16.7M3.19%1.17%Not reportedQ2 2013
XENEXenon Pharmaceuticals Inc.$15.1M2.89%0.26%Not reportedQ3 2015
CYTKCytokinetics Inc$14.7M2.79%0.14%-20.9%Q4 2015
RCUSArcus Biosciences, Inc.$13.6M2.60%0.35%-0.5%Q1 2018
ASNDAscendis Pharma A/S$12.9M2.47%0.08%+109.1%Q1 2015
NBIXNeurocrine Biosciences Inc$9.74M1.86%0.06%-18.2%Q3 2014
AXGNAxogen, Inc.$9.65M1.84%0.39%-16.4%Q4 2021
PODDInsulet Corp$9.42M1.80%0.09%+469.2%Q2 2013
EWTXEdgewise Therapeutics, Inc.$9.22M1.76%0.21%+102.1%Q1 2022
BCAXBicara Therapeutics Inc.$8.46M1.61%0.43%-32.4%Q4 2024
SNDXSyndax Pharmaceuticals Inc$7.33M1.40%0.38%+54.2%Q2 2020
MPLTMapLight Therapeutics, Inc.$6.13M1.17%0.38%Not reportedQ4 2025
LRMRLarimar Therapeutics, Inc.$6.12M1.17%1.93%-1.0%Q2 2020
IPSCCentury Therapeutics, Inc.$5.88M1.12%1.33%-1.4%Q2 2021
DXCMDexcom Inc$5.81M1.11%0.02%Not reportedQ3 2017
IMVTImmunovant, Inc.$5.76M1.10%0.07%-0.7%Q3 2023
INGNInogen Inc$5.45M1.04%3.16%Not reportedQ1 2019
TNDMTandem Diabetes Care Inc$5.36M1.02%0.51%Not reportedQ1 2015
ALKSAlkermes plc.$5.31M1.01%0.06%-27.4%Q2 2024
STOKStoke Therapeutics, Inc.$4.28M0.82%0.21%Not reportedQ1 2024
ALLOAllogene Therapeutics, Inc.$4.16M0.79%0.58%+46.0%Q2 2024
BCRXBiocryst Pharmaceuticals Inc$4M0.76%0.16%-7.0%Q3 2014
LKFTLakefront Biotherapeutics NV$3.9M0.74%0.20%Not reportedQ3 2015
KIDSOrthopediatrics Corp$3.62M0.69%0.74%+97.7%Q1 2026
HELPCybin Inc.$3.4M0.65%1.00%+3.2%Q4 2025
RAPPRapport Therapeutics, Inc.$3.13M0.60%0.16%Not reportedQ3 2025
KYMRKymera Therapeutics, Inc.$3.1M0.59%0.03%NewQ2 2026
PRQRProQR Therapeutics N.V.$2.85M0.54%1.45%-2.4%Q4 2017
NGNENeurogene Inc.$2.8M0.53%0.56%+57.2%Q2 2024
ANLAdlai Nortye Ltd.$2.75M0.53%Not reportedNewQ2 2026
PRCTPROCEPT BioRobotics Corp$2.71M0.52%0.21%Not reportedQ2 2023
AQSTAquestive Therapeutics, Inc.$2.69M0.51%0.51%+75.3%Q1 2024
CLDXCelldex Therapeutics, Inc.$2.55M0.49%0.09%Not reportedQ3 2025
GPCRStructure Therapeutics Inc.$2.5M0.48%0.02%Not reportedQ2 2024
ALGNAlign Technology Inc$2.36M0.45%0.02%-6.7%Q4 2024
VKTXViking Therapeutics, Inc.$2.32M0.44%0.05%Not reportedQ4 2018
NGENNervgen Pharma Corp.$2.16M0.41%1.32%NewQ2 2026
BHVNBiohaven Ltd.$2.05M0.39%0.09%-83.7%Q2 2018
MAZEMaze Therapeutics, Inc.$1.94M0.37%0.12%+85.7%Q1 2026
ALECAlector, Inc.$1.83M0.35%0.81%Not reportedQ1 2019
LXEOLexeo Therapeutics, Inc.$1.76M0.33%0.48%Not reportedQ3 2024
PROFProfound Medical Corp.$1.73M0.33%0.71%-1.0%Q4 2025
RNAAtrium Therapeutics, Inc.$1.72M0.33%0.75%NewQ2 2026
ANNXAnnexon, Inc.$1.7M0.32%0.20%+152.8%Q3 2021
Q1 2026Reported May 15, 202680 positions
RVMDRevolution Medicines, Inc.$56.5M12.85%0.29%-3.9%Q4 2020
STXSStereotaxis, Inc.$25.2M5.73%14.07%Not reportedQ2 2013
DAWNDay One Biopharmaceuticals, Inc.$21M4.77%0.95%-2.1%Q2 2023
ATRCAtriCure, Inc.$17M3.88%1.18%Not reportedQ2 2013
IDYAIDEAYA Biosciences, Inc.$15.9M3.61%0.54%-5.9%Q3 2020
XENEXenon Pharmaceuticals Inc.$14.6M3.32%0.26%-12.9%Q3 2015
CYTKCytokinetics Inc$14.3M3.26%0.18%-41.4%Q4 2015
CMPSCOMPASS Pathways plc$13.4M3.04%1.79%+198.2%Q1 2022
NKTRNektar Therapeutics$11.9M2.70%0.81%+120.2%Q2 2025
RCUSArcus Biosciences, Inc.$9.59M2.18%0.35%+2.9%Q1 2018
NBIXNeurocrine Biosciences Inc$9.3M2.12%0.07%Not reportedQ3 2014
LRMRLarimar Therapeutics, Inc.$9.13M2.08%1.95%+116.1%Q2 2020
BCAXBicara Therapeutics Inc.$8.39M1.91%0.64%+61.2%Q4 2024
AXGNAxogen, Inc.$8.28M1.88%0.47%-47.6%Q4 2021
BHVNBiohaven Ltd.$7.15M1.63%0.56%-11.5%Q2 2018
TNDMTandem Diabetes Care Inc$6.81M1.55%0.52%Not reportedQ1 2015
DNLIDenali Therapeutics Inc.$6.12M1.39%0.20%Not reportedQ1 2025
IPSCCentury Therapeutics, Inc.$5.5M1.25%1.35%-12.9%Q2 2021
DXCMDexcom Inc$5.42M1.23%0.02%-2.3%Q3 2017
KALVKalVista Pharmaceuticals, Inc.$5.38M1.22%0.52%-25.1%Q3 2018
ASNDAscendis Pharma A/S$5.3M1.21%0.04%-17.7%Q1 2015
MBXMBX Biosciences, Inc.$5.24M1.19%0.37%+6.2%Q3 2025
INGNInogen Inc$5.22M1.19%3.09%+2.2%Q1 2019
SNDXSyndax Pharmaceuticals Inc$5.08M1.16%0.25%-21.8%Q2 2020
ALKSAlkermes plc.$4.93M1.12%0.08%+7.1%Q2 2024
STOKStoke Therapeutics, Inc.$4.26M0.97%0.21%+20.2%Q1 2024
BCRXBiocryst Pharmaceuticals Inc$4.1M0.93%0.17%+2.9%Q3 2014
LKFTLakefront Biotherapeutics NV$3.91M0.89%0.20%Not reportedQ3 2015
IMVTImmunovant, Inc.$3.74M0.85%0.07%Not reportedQ3 2023
EWTXEdgewise Therapeutics, Inc.$3.54M0.80%0.10%-29.7%Q1 2022
MPLTMapLight Therapeutics, Inc.$3.48M0.79%0.38%+19.0%Q4 2025
ALLOAllogene Therapeutics, Inc.$3.34M0.76%0.56%-0.7%Q2 2024
PRCTPROCEPT BioRobotics Corp$3M0.68%0.21%Not reportedQ2 2023
ALGNAlign Technology Inc$2.57M0.58%0.02%-6.3%Q4 2024
PRQRProQR Therapeutics N.V.$2.54M0.58%1.49%Not reportedQ4 2017
HELPCybin Inc.$2.39M0.54%0.97%+9.5%Q4 2025
RAPPRapport Therapeutics, Inc.$2.35M0.53%0.16%Not reportedQ3 2025
PODDInsulet Corp$2.28M0.52%0.02%+58.2%Q2 2013
GPCRStructure Therapeutics Inc.$2.24M0.51%0.02%+25.7%Q2 2024
IMTXImmatics N.V.$2.22M0.51%0.17%-13.5%Q4 2023
CLDXCelldex Therapeutics, Inc.$2.17M0.49%0.10%Not reportedQ3 2025
LXEOLexeo Therapeutics, Inc.$2.16M0.49%0.51%+10.6%Q3 2024
ALECAlector, Inc.$1.95M0.44%0.82%Not reportedQ1 2019
VKTXViking Therapeutics, Inc.$1.94M0.44%0.05%Not reportedQ4 2018
KURAKura Oncology, Inc.$1.92M0.44%0.27%Not reportedQ3 2017
PROFProfound Medical Corp.$1.7M0.39%0.72%-8.0%Q4 2025
FULCFulcrum Therapeutics, Inc.$1.57M0.36%0.31%NewQ1 2026
AQSTAquestive Therapeutics, Inc.$1.53M0.35%0.30%-2.0%Q1 2024
MDWDMediWound Ltd.$1.52M0.35%0.74%-16.9%Q3 2022
KIDSOrthopediatrics Corp$1.52M0.35%0.38%NewQ1 2026
Q4 2025Reported Feb 17, 202674 positions
RVMDRevolution Medicines, Inc.$48.1M11.18%0.31%-8.0%Q4 2020
STXSStereotaxis, Inc.$31.5M7.31%14.66%Not reportedQ2 2013
ATRCAtriCure, Inc.$23.6M5.49%1.20%+0.9%Q2 2013
CYTKCytokinetics Inc$23.6M5.48%0.30%-6.1%Q4 2015
IDYAIDEAYA Biosciences, Inc.$17.5M4.07%0.58%-6.2%Q3 2020
AXGNAxogen, Inc.$15.6M3.63%1.01%-35.8%Q4 2021
XENEXenon Pharmaceuticals Inc.$12.9M3.00%0.36%Not reportedQ3 2015
BHVNBiohaven Ltd.$10.8M2.51%0.72%+306.1%Q2 2018
RCUSArcus Biosciences, Inc.$10.3M2.39%0.34%-31.3%Q1 2018
NBIXNeurocrine Biosciences Inc$10M2.33%0.07%Not reportedQ3 2014
DAWNDay One Biopharmaceuticals, Inc.$9.31M2.16%0.97%Not reportedQ2 2023
TNDMTandem Diabetes Care Inc$7.81M1.81%0.52%Not reportedQ1 2015
ASNDAscendis Pharma A/S$6.01M1.40%0.05%-15.1%Q1 2015
DXCMDexcom Inc$5.86M1.36%0.02%+34.7%Q3 2017
SNDXSyndax Pharmaceuticals Inc$5.84M1.36%0.32%-44.5%Q2 2020
KALVKalVista Pharmaceuticals, Inc.$5.76M1.34%0.70%-15.6%Q3 2018
CMPSCOMPASS Pathways plc$5.6M1.30%0.84%Not reportedQ1 2022
INGNInogen Inc$5.56M1.29%3.04%+36.6%Q1 2019
DNLIDenali Therapeutics Inc.$5.26M1.22%0.20%+89.0%Q1 2025
MBXMBX Biosciences, Inc.$5.21M1.21%0.37%+94.4%Q3 2025
BCAXBicara Therapeutics Inc.$4.4M1.02%0.46%-17.5%Q4 2024
LKFTLakefront Biotherapeutics NV$4.26M0.99%0.20%Not reportedQ3 2015
ATXSAstria Therapeutics, Inc.$3.99M0.93%0.53%-4.7%Q1 2023
EWTXEdgewise Therapeutics, Inc.$3.96M0.92%0.15%-25.3%Q1 2022
IMVTImmunovant, Inc.$3.83M0.89%0.07%-21.4%Q3 2023
PRCTPROCEPT BioRobotics Corp$3.78M0.88%0.21%Not reportedQ2 2023
HELPCybin Inc.$3.72M0.86%2.11%NewQ4 2025
ALKSAlkermes plc.$3.64M0.85%0.08%-3.3%Q2 2024
LRMRLarimar Therapeutics, Inc.$3.58M0.83%1.13%-8.6%Q2 2020
STOKStoke Therapeutics, Inc.$3.46M0.80%0.18%-35.9%Q1 2024
LXEOLexeo Therapeutics, Inc.$3.38M0.79%0.47%-4.8%Q3 2024
BCRXBiocryst Pharmaceuticals Inc$3.26M0.76%0.20%+91.6%Q3 2014
NKTRNektar Therapeutics$3.17M0.74%0.37%+36.4%Q2 2025
PRQRProQR Therapeutics N.V.$3.17M0.74%1.49%Not reportedQ4 2017
IPSCCentury Therapeutics, Inc.$2.78M0.65%3.19%+63.9%Q2 2021
IMTXImmatics N.V.$2.74M0.64%0.19%+11.1%Q4 2023
GPCRStructure Therapeutics Inc.$2.57M0.60%0.02%-37.3%Q2 2024
MPLTMapLight Therapeutics, Inc.$2.53M0.59%0.33%NewQ4 2025
ALGNAlign Technology Inc$2.5M0.58%0.02%+45.5%Q4 2024
KURAKura Oncology, Inc.$2.45M0.57%0.27%-49.1%Q3 2017
AQSTAquestive Therapeutics, Inc.$2.43M0.56%0.31%-26.7%Q1 2024
RAPPRapport Therapeutics, Inc.$2.28M0.53%0.16%Not reportedQ3 2025
PROFProfound Medical Corp.$2.25M0.52%0.79%NewQ4 2025
SPRYARS Pharmaceuticals, Inc.$2.21M0.51%0.19%+35.3%Q4 2023
MDWDMediWound Ltd.$2.1M0.49%0.89%Not reportedQ3 2022
VKTXViking Therapeutics, Inc.$2.09M0.49%0.05%-7.8%Q4 2018
PODDInsulet Corp$1.95M0.45%0.01%Not reportedQ2 2013
ALLOAllogene Therapeutics, Inc.$1.89M0.44%0.60%Not reportedQ2 2024
CLDXCelldex Therapeutics, Inc.$1.86M0.43%0.10%+179.5%Q3 2025
TELATELA Bio, Inc.$1.7M0.39%3.24%Not reportedQ4 2024
Q3 2025Reported Nov 14, 202572 positions
STXSStereotaxis, Inc.$42.5M10.51%15.09%Not reportedQ2 2013
RVMDRevolution Medicines, Inc.$30.7M7.58%0.35%-3.0%Q4 2020
CYTKCytokinetics Inc$21.7M5.36%0.33%-0.8%Q4 2015
ATRCAtriCure, Inc.$20.9M5.16%1.19%Not reportedQ2 2013
MRUSMerus N.V.$20.8M5.13%0.29%-44.7%Q1 2021
IDYAIDEAYA Biosciences, Inc.$14.7M3.63%0.62%-12.8%Q3 2020
AXGNAxogen, Inc.$13.2M3.27%1.61%+0.1%Q4 2021
XENEXenon Pharmaceuticals Inc.$11.6M2.86%0.37%Not reportedQ3 2015
NBIXNeurocrine Biosciences Inc$9.91M2.45%0.07%Not reportedQ3 2014
RCUSArcus Biosciences, Inc.$8.54M2.11%0.59%Not reportedQ1 2018
SNDXSyndax Pharmaceuticals Inc$7.7M1.90%0.58%-7.9%Q2 2020
DAWNDay One Biopharmaceuticals, Inc.$7.04M1.74%0.97%+13.7%Q2 2023
ASNDAscendis Pharma A/S$6.6M1.63%0.05%-54.4%Q1 2015
KALVKalVista Pharmaceuticals, Inc.$5.15M1.27%0.84%-27.3%Q3 2018
BCAXBicara Therapeutics Inc.$5.01M1.24%0.58%Not reportedQ4 2024
INGNInogen Inc$4.95M1.22%2.23%Not reportedQ1 2019
CMPSCOMPASS Pathways plc$4.65M1.15%0.84%Not reportedQ1 2022
LKFTLakefront Biotherapeutics NV$4.51M1.11%0.20%Not reportedQ3 2015
DXCMDexcom Inc$4.41M1.09%0.02%Not reportedQ3 2017
TNDMTandem Diabetes Care Inc$4.31M1.07%0.52%+20.7%Q1 2015
KURAKura Oncology, Inc.$4.1M1.01%0.53%Not reportedQ3 2017
ALKSAlkermes plc.$4.04M1.00%0.08%+29.9%Q2 2024
STOKStoke Therapeutics, Inc.$3.99M0.99%0.31%-66.2%Q1 2024
SLNOSoleno Therapeutics Inc$3.58M0.89%0.10%Not reportedQ2 2020
BHVNBiohaven Ltd.$3.53M0.87%0.22%Not reportedQ2 2018
EWTXEdgewise Therapeutics, Inc.$3.47M0.86%0.20%-10.3%Q1 2022
PRQRProQR Therapeutics N.V.$3.34M0.82%1.49%Not reportedQ4 2017
LRMRLarimar Therapeutics, Inc.$3.32M0.82%1.20%+176.7%Q2 2020
CMPXCompass Therapeutics, Inc.$3.31M0.82%0.53%+79.8%Q4 2021
MLYSMineralys Therapeutics, Inc.$3.17M0.78%0.11%-77.5%Q4 2023
NKTRNektar Therapeutics$3.13M0.77%0.28%+450.0%Q2 2025
IMVTImmunovant, Inc.$3.09M0.76%0.11%Not reportedQ3 2023
KRROKorro Bio, Inc.$2.91M0.72%0.65%+5.4%Q1 2025
AQSTAquestive Therapeutics, Inc.$2.87M0.71%0.42%+261.0%Q1 2024
DNLIDenali Therapeutics Inc.$2.45M0.60%0.11%Not reportedQ1 2025
LXEOLexeo Therapeutics, Inc.$2.38M0.59%0.65%-5.3%Q3 2024
ALECAlector, Inc.$2.36M0.58%0.74%-12.6%Q1 2019
ATXSAstria Therapeutics, Inc.$2.33M0.58%0.57%-1.5%Q1 2023
RAPPRapport Therapeutics, Inc.$2.23M0.55%0.16%NewQ3 2025
TELATELA Bio, Inc.$2.15M0.53%3.57%Not reportedQ4 2024
PODDInsulet Corp$2.12M0.52%0.01%-30.6%Q2 2013
MDWDMediWound Ltd.$2.05M0.51%1.05%+76.2%Q3 2022
ARAYAccuray Inc$2.04M0.50%1.08%Not reportedQ2 2019
IMTXImmatics N.V.$2M0.49%0.19%-4.1%Q4 2023
ALLOAllogene Therapeutics, Inc.$1.71M0.42%0.62%Not reportedQ2 2024
VKTXViking Therapeutics, Inc.$1.7M0.42%0.06%Not reportedQ4 2018
BCRXBiocryst Pharmaceuticals Inc$1.66M0.41%0.10%Not reportedQ3 2014
GPCRStructure Therapeutics Inc.$1.65M0.41%0.03%Not reportedQ2 2024
MBXMBX Biosciences, Inc.$1.49M0.37%0.19%NewQ3 2025
SPRYARS Pharmaceuticals, Inc.$1.41M0.35%0.14%Not reportedQ4 2023
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.